Amexdrug Corp (AXRX)
0.0021
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Amexdrug Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2013 | 16.57% |
| March 31, 2013 | 21.97% |
| December 31, 2012 | 6.06% |
| September 30, 2012 | 10.84% |
| June 30, 2012 | 11.06% |
| March 31, 2012 | 16.54% |
| December 31, 2011 | -2.82% |
| September 30, 2011 | 10.43% |
| June 30, 2011 | 8.88% |
| March 31, 2011 | 15.18% |
| December 31, 2010 | 7.00% |
| September 30, 2010 | 8.75% |
| June 30, 2010 | 9.20% |
| March 31, 2010 | 8.50% |
| December 31, 2009 | 5.74% |
| September 30, 2009 | 4.10% |
| June 30, 2009 | 10.55% |
| March 31, 2009 | 10.22% |
| December 31, 2008 | 6.95% |
| September 30, 2008 | 10.62% |
| June 30, 2008 | 5.65% |
| March 31, 2008 | 9.18% |
| December 31, 2007 | 1.61% |
| September 30, 2007 | 6.64% |
| June 30, 2007 | 4.78% |
| Date | Value |
|---|---|
| March 31, 2007 | 10.99% |
| December 31, 2006 | 8.89% |
| September 30, 2006 | 7.49% |
| June 30, 2006 | 8.89% |
| March 31, 2006 | 12.94% |
| December 31, 2005 | 5.08% |
| September 30, 2005 | 7.05% |
| June 30, 2005 | 9.58% |
| March 31, 2005 | 5.59% |
| December 31, 2004 | 0.24% |
| September 30, 2004 | -0.38% |
| June 30, 2004 | 10.10% |
| March 31, 2004 | 4.28% |
| December 31, 2003 | -13.88% |
| September 30, 2003 | 4.26% |
| June 30, 2003 | 2.70% |
| March 31, 2003 | 6.03% |
| December 31, 2002 | 0.43% |
| September 30, 2002 | 4.65% |
| June 30, 2002 | 3.05% |
| March 31, 2002 | 2.86% |
| December 31, 2001 | |
| September 30, 2001 | |
| June 30, 2001 | |
| March 31, 2001 | -3.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |